CompletedNCT02579642
Low-Dose Ketamine With Propofol for ECT in Depression
About this title
Read the official source — NCT02579642Medication studyAges 18–70Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
What did participation involve?
Depending on the group, the protocol specifies the study medication (ketamine) or a placebo (an inactive comparison treatment).
- Listed locations
- Edmonton and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateOctober 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 48
- Sponsor
- University of Alberta
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT02579642
- Official title
Show the full official title
Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Edmonton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Alberta, a university.
Did this study involve medication?
Yes. The study involved medication, including ketamine and Placebo.
Who was this study for?
Listed age limits: 18 years to 70 years.
